The global Rheumatology Therapeutics market was valued at US$ 46360 million in 2023 and is anticipated to reach US$ 54090 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.

Rheumatology Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Rheumatology Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatology Therapeutics.

Report Scope

The Rheumatology Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rheumatology Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rheumatology Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Rheumatology Therapeutics Market Report

Report Metric	Details
Report Name	Rheumatology Therapeutics Market
Accounted market size in 2023	US$ 46360 million
Forecasted market size in 2030	US$ 54090 million
CAGR	2.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Disease Modifying Anti-rheumatic Drugs Nonsteroidal Anti-inflammatory Drugs Corticosteroids Uric Acid Drugs Others
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer, Bristol-Myers Squibb Company, Merck & Co.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rheumatology Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Rheumatology Therapeutics Market growing?

Ans: The Rheumatology Therapeutics Market witnessing a CAGR of 2.2% during the forecast period 2024-2030.

What is the Rheumatology Therapeutics Market size in 2030?

Ans: The Rheumatology Therapeutics Market size in 2030 will be US$ 54090 million.

Who are the main players in the Rheumatology Therapeutics Market report?

Ans: The main players in the Rheumatology Therapeutics Market are Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer, Bristol-Myers Squibb Company, Merck & Co.

What are the Application segmentation covered in the Rheumatology Therapeutics Market report?

Ans: The Applications covered in the Rheumatology Therapeutics Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Rheumatology Therapeutics Market report?

Ans: The Types covered in the Rheumatology Therapeutics Market report are Disease Modifying Anti-rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Rheumatology Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Disease Modifying Anti-rheumatic Drugs

1.2.3 Nonsteroidal Anti-inflammatory Drugs

1.2.4 Corticosteroids

1.2.5 Uric Acid Drugs

1.2.6 Others

1.3 Market by Application

1.3.1 Global Rheumatology Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Rheumatology Therapeutics Market Perspective (2019-2030)

2.2 Rheumatology Therapeutics Growth Trends by Region

2.2.1 Global Rheumatology Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Rheumatology Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Rheumatology Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Rheumatology Therapeutics Market Dynamics

2.3.1 Rheumatology Therapeutics Industry Trends

2.3.2 Rheumatology Therapeutics Market Drivers

2.3.3 Rheumatology Therapeutics Market Challenges

2.3.4 Rheumatology Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Rheumatology Therapeutics Players by Revenue

3.1.1 Global Top Rheumatology Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Rheumatology Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Rheumatology Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Rheumatology Therapeutics Revenue

3.4 Global Rheumatology Therapeutics Market Concentration Ratio

3.4.1 Global Rheumatology Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Therapeutics Revenue in 2023

3.5 Rheumatology Therapeutics Key Players Head office and Area Served

3.6 Key Players Rheumatology Therapeutics Product Solution and Service

3.7 Date of Enter into Rheumatology Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Rheumatology Therapeutics Breakdown Data by Type

4.1 Global Rheumatology Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Rheumatology Therapeutics Forecasted Market Size by Type (2025-2030)

5 Rheumatology Therapeutics Breakdown Data by Application

5.1 Global Rheumatology Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Rheumatology Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Rheumatology Therapeutics Market Size (2019-2030)

6.2 North America Rheumatology Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Rheumatology Therapeutics Market Size by Country (2019-2024)

6.4 North America Rheumatology Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Rheumatology Therapeutics Market Size (2019-2030)

7.2 Europe Rheumatology Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Rheumatology Therapeutics Market Size by Country (2019-2024)

7.4 Europe Rheumatology Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Rheumatology Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Rheumatology Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Rheumatology Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Rheumatology Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Rheumatology Therapeutics Market Size (2019-2030)

9.2 Latin America Rheumatology Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Rheumatology Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Rheumatology Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Rheumatology Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Rheumatology Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Rheumatology Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Rheumatology Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda Pharmaceutical

11.1.1 Takeda Pharmaceutical Company Detail

11.1.2 Takeda Pharmaceutical Business Overview

11.1.3 Takeda Pharmaceutical Rheumatology Therapeutics Introduction

11.1.4 Takeda Pharmaceutical Revenue in Rheumatology Therapeutics Business (2019-2024)

11.1.5 Takeda Pharmaceutical Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Detail

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Rheumatology Therapeutics Introduction

11.2.4 Sanofi Revenue in Rheumatology Therapeutics Business (2019-2024)

11.2.5 Sanofi Recent Development

11.3 Genentech

11.3.1 Genentech Company Detail

11.3.2 Genentech Business Overview

11.3.3 Genentech Rheumatology Therapeutics Introduction

11.3.4 Genentech Revenue in Rheumatology Therapeutics Business (2019-2024)

11.3.5 Genentech Recent Development

11.4 Novartis

11.4.1 Novartis Company Detail

11.4.2 Novartis Business Overview

11.4.3 Novartis Rheumatology Therapeutics Introduction

11.4.4 Novartis Revenue in Rheumatology Therapeutics Business (2019-2024)

11.4.5 Novartis Recent Development

11.5 Janssen Biotech

11.5.1 Janssen Biotech Company Detail

11.5.2 Janssen Biotech Business Overview

11.5.3 Janssen Biotech Rheumatology Therapeutics Introduction

11.5.4 Janssen Biotech Revenue in Rheumatology Therapeutics Business (2019-2024)

11.5.5 Janssen Biotech Recent Development

11.6 Amgen

11.6.1 Amgen Company Detail

11.6.2 Amgen Business Overview

11.6.3 Amgen Rheumatology Therapeutics Introduction

11.6.4 Amgen Revenue in Rheumatology Therapeutics Business (2019-2024)

11.6.5 Amgen Recent Development

11.7 AbbVie

11.7.1 AbbVie Company Detail

11.7.2 AbbVie Business Overview

11.7.3 AbbVie Rheumatology Therapeutics Introduction

11.7.4 AbbVie Revenue in Rheumatology Therapeutics Business (2019-2024)

11.7.5 AbbVie Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Detail

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Rheumatology Therapeutics Introduction

11.8.4 Pfizer Revenue in Rheumatology Therapeutics Business (2019-2024)

11.8.5 Pfizer Recent Development

11.9 Bristol-Myers Squibb Company

11.9.1 Bristol-Myers Squibb Company Company Detail

11.9.2 Bristol-Myers Squibb Company Business Overview

11.9.3 Bristol-Myers Squibb Company Rheumatology Therapeutics Introduction

11.9.4 Bristol-Myers Squibb Company Revenue in Rheumatology Therapeutics Business (2019-2024)

11.9.5 Bristol-Myers Squibb Company Recent Development

11.10 Merck & Co.

11.10.1 Merck & Co. Company Detail

11.10.2 Merck & Co. Business Overview

11.10.3 Merck & Co. Rheumatology Therapeutics Introduction

11.10.4 Merck & Co. Revenue in Rheumatology Therapeutics Business (2019-2024)

11.10.5 Merck & Co. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Takeda Pharmaceutical

Bristol Myers Squibb Company

Merck

List of Tables

Table 1. Global Rheumatology Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Disease Modifying Anti-rheumatic Drugs

Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs

Table 4. Key Players of Corticosteroids

Table 5. Key Players of Uric Acid Drugs

Table 6. Key Players of Others

Table 7. Global Rheumatology Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Rheumatology Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Rheumatology Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Rheumatology Therapeutics Market Share by Region (2019-2024)

Table 11. Global Rheumatology Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Rheumatology Therapeutics Market Share by Region (2025-2030)

Table 13. Rheumatology Therapeutics Market Trends

Table 14. Rheumatology Therapeutics Market Drivers

Table 15. Rheumatology Therapeutics Market Challenges

Table 16. Rheumatology Therapeutics Market Restraints

Table 17. Global Rheumatology Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Rheumatology Therapeutics Market Share by Players (2019-2024)

Table 19. Global Top Rheumatology Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Therapeutics as of 2023)

Table 20. Ranking of Global Top Rheumatology Therapeutics Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Rheumatology Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Rheumatology Therapeutics Product Solution and Service

Table 24. Date of Enter into Rheumatology Therapeutics Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Rheumatology Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Rheumatology Therapeutics Revenue Market Share by Type (2019-2024)

Table 28. Global Rheumatology Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Rheumatology Therapeutics Revenue Market Share by Type (2025-2030)

Table 30. Global Rheumatology Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Rheumatology Therapeutics Revenue Market Share by Application (2019-2024)

Table 32. Global Rheumatology Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Rheumatology Therapeutics Revenue Market Share by Application (2025-2030)

Table 34. North America Rheumatology Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Rheumatology Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Rheumatology Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Rheumatology Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Rheumatology Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Rheumatology Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Rheumatology Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Rheumatology Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Rheumatology Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Rheumatology Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Rheumatology Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Rheumatology Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Rheumatology Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Rheumatology Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Rheumatology Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 49. Takeda Pharmaceutical Company Detail

Table 50. Takeda Pharmaceutical Business Overview

Table 51. Takeda Pharmaceutical Rheumatology Therapeutics Product

Table 52. Takeda Pharmaceutical Revenue in Rheumatology Therapeutics Business (2019-2024) & (US$ Million)

Table 53. Takeda Pharmaceutical Recent Development

Table 54. Sanofi Company Detail

Table 55. Sanofi Business Overview

Table 56. Sanofi Rheumatology Therapeutics Product

Table 57. Sanofi Revenue in Rheumatology Therapeutics Business (2019-2024) & (US$ Million)

Table 58. Sanofi Recent Development

Table 59. Genentech Company Detail

Table 60. Genentech Business Overview

Table 61. Genentech Rheumatology Therapeutics Product

Table 62. Genentech Revenue in Rheumatology Therapeutics Business (2019-2024) & (US$ Million)

Table 63. Genentech Recent Development

Table 64. Novartis Company Detail

Table 65. Novartis Business Overview

Table 66. Novartis Rheumatology Therapeutics Product

Table 67. Novartis Revenue in Rheumatology Therapeutics Business (2019-2024) & (US$ Million)

Table 68. Novartis Recent Development

Table 69. Janssen Biotech Company Detail

Table 70. Janssen Biotech Business Overview

Table 71. Janssen Biotech Rheumatology Therapeutics Product

Table 72. Janssen Biotech Revenue in Rheumatology Therapeutics Business (2019-2024) & (US$ Million)

Table 73. Janssen Biotech Recent Development

Table 74. Amgen Company Detail

Table 75. Amgen Business Overview

Table 76. Amgen Rheumatology Therapeutics Product

Table 77. Amgen Revenue in Rheumatology Therapeutics Business (2019-2024) & (US$ Million)

Table 78. Amgen Recent Development

Table 79. AbbVie Company Detail

Table 80. AbbVie Business Overview

Table 81. AbbVie Rheumatology Therapeutics Product

Table 82. AbbVie Revenue in Rheumatology Therapeutics Business (2019-2024) & (US$ Million)

Table 83. AbbVie Recent Development

Table 84. Pfizer Company Detail

Table 85. Pfizer Business Overview

Table 86. Pfizer Rheumatology Therapeutics Product

Table 87. Pfizer Revenue in Rheumatology Therapeutics Business (2019-2024) & (US$ Million)

Table 88. Pfizer Recent Development

Table 89. Bristol-Myers Squibb Company Company Detail

Table 90. Bristol-Myers Squibb Company Business Overview

Table 91. Bristol-Myers Squibb Company Rheumatology Therapeutics Product

Table 92. Bristol-Myers Squibb Company Revenue in Rheumatology Therapeutics Business (2019-2024) & (US$ Million)

Table 93. Bristol-Myers Squibb Company Recent Development

Table 94. Merck & Co. Company Detail

Table 95. Merck & Co. Business Overview

Table 96. Merck & Co. Rheumatology Therapeutics Product

Table 97. Merck & Co. Revenue in Rheumatology Therapeutics Business (2019-2024) & (US$ Million)

Table 98. Merck & Co. Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Rheumatology Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Rheumatology Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Disease Modifying Anti-rheumatic Drugs Features

Figure 4. Nonsteroidal Anti-inflammatory Drugs Features

Figure 5. Corticosteroids Features

Figure 6. Uric Acid Drugs Features

Figure 7. Others Features

Figure 8. Global Rheumatology Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Rheumatology Therapeutics Market Share by Application: 2023 VS 2030

Figure 10. Hospital Pharmacy Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. Online Pharmacy Case Studies

Figure 13. Rheumatology Therapeutics Report Years Considered

Figure 14. Global Rheumatology Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Rheumatology Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Rheumatology Therapeutics Market Share by Region: 2023 VS 2030

Figure 17. Global Rheumatology Therapeutics Market Share by Players in 2023

Figure 18. Global Top Rheumatology Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Therapeutics as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Rheumatology Therapeutics Revenue in 2023

Figure 20. North America Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Rheumatology Therapeutics Market Share by Country (2019-2030)

Figure 22. United States Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Rheumatology Therapeutics Market Share by Country (2019-2030)

Figure 26. Germany Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Rheumatology Therapeutics Market Share by Region (2019-2030)

Figure 34. China Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Rheumatology Therapeutics Market Share by Country (2019-2030)

Figure 42. Mexico Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Rheumatology Therapeutics Market Share by Country (2019-2030)

Figure 46. Turkey Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Rheumatology Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Therapeutics Business (2019-2024)

Figure 49. Sanofi Revenue Growth Rate in Rheumatology Therapeutics Business (2019-2024)

Figure 50. Genentech Revenue Growth Rate in Rheumatology Therapeutics Business (2019-2024)

Figure 51. Novartis Revenue Growth Rate in Rheumatology Therapeutics Business (2019-2024)

Figure 52. Janssen Biotech Revenue Growth Rate in Rheumatology Therapeutics Business (2019-2024)

Figure 53. Amgen Revenue Growth Rate in Rheumatology Therapeutics Business (2019-2024)

Figure 54. AbbVie Revenue Growth Rate in Rheumatology Therapeutics Business (2019-2024)

Figure 55. Pfizer Revenue Growth Rate in Rheumatology Therapeutics Business (2019-2024)

Figure 56. Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Therapeutics Business (2019-2024)

Figure 57. Merck & Co. Revenue Growth Rate in Rheumatology Therapeutics Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions